Eyes with a concomitant diagnosis of proliferative diabetic retinopathy or with history of anti-VEGF treatment were excluded, in order to focus on the effects of diabetes in itself and not on the effects of overt complications related to the disease. This evidence concerns the gene VEGFA and diabetes mellitus.